Emtricitabine Unknown Status Phase 2 Trials for Tuberculosis (TB) / Human Immunodeficiency Virus (HIV) Infections Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00474435Pharmacokinetics of Emtricitabine/Tenofovir/Efavirenz in HIV-infected Patients With Tuberculosis
NCT00017992Emtricitabine Given Once A Day With Other Anti-HIV Drugs in Children With HIV